• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胸腺制剂和抗结核药物对实验动物免疫反应性及结核病程的影响]

[Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals].

作者信息

Demidov S V, Miasnikov V G, Chernushenko E F, Osipova L S

出版信息

Probl Tuberk. 1991(12):52-4.

PMID:1803376
Abstract

The effects of thymogen, thymalin and vilosen in combination with antituberculous drugs (isoniazid, streptomycin, rifampicin) were studied on 240 CBA mice with experimental tuberculosis. Thymus preparations supplemented to the complex treatment of experimental tuberculosis significantly increased their lifespan, contributed to a decrease in the index of spleen weight lung density and significantly increased the count of T lymphocytes and their proliferative activity as compared to those on antituberculous drugs alone. Thymogen was found to be the most effective in the complex treatment of experimental tuberculosis, whereas vilosen was the least. Thymogen plus vilosen proved to be the most beneficial combination of drugs.

摘要

研究了胸腺生成素、胸腺素和维洛辛与抗结核药物(异烟肼、链霉素、利福平)联合使用对240只患有实验性结核病的CBA小鼠的影响。在实验性结核病的综合治疗中添加胸腺制剂可显著延长小鼠寿命,有助于降低脾脏重量肺密度指数,并与单独使用抗结核药物相比,显著增加T淋巴细胞计数及其增殖活性。发现胸腺生成素在实验性结核病的综合治疗中最有效,而维洛辛最无效。胸腺生成素加维洛辛被证明是最有益的药物组合。

相似文献

1
[Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals].[胸腺制剂和抗结核药物对实验动物免疫反应性及结核病程的影响]
Probl Tuberk. 1991(12):52-4.
2
[The validation of the use of thymic preparations in tuberculous infection by experimental data].[通过实验数据验证胸腺制剂在结核感染中的应用]
Vrach Delo. 1991 May(5):53-5.
3
[Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].[免疫疗法在慢性破坏性肺结核联合治疗中的应用]
Probl Tuberk. 1994(3):16-9.
4
[Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].[在结核病患者联合治疗中使用胸腺制剂和结核菌素疗法的免疫学标准]
Probl Tuberk. 1988(3):27-31.
5
[Immunotherapy of pulmonary tuberculosis].[肺结核的免疫疗法]
Probl Tuberk. 1998(6):23-6.
6
[Effect of thymagen, thymalin and vilosen on the cAMP and cGMP levels and phosphodiesterase activity in spleen lymphocytes during sensitization and anaphylactic shock].[胸腺生成素、胸腺素和维洛辛对致敏和过敏性休克期间脾淋巴细胞中环磷酸腺苷(cAMP)和环磷酸鸟苷(cGMP)水平及磷酸二酯酶活性的影响]
Ukr Biokhim Zh (1978). 1991 Jul-Aug;63(4):104-6.
7
[Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].[胸腺制剂(T-激活素、胸腺素)治疗丹毒感染的临床疗效]
Sov Med. 1990(6):111-3.
8
[Effect of thymus polypeptide fractions on the development of rat thymus and spleen in organ culture].[胸腺多肽组分对器官培养中大鼠胸腺和脾脏发育的影响]
Tsitologiia. 1999;41(10):889-94.
9
[Radiation protective effect of low molecular weight thymus preparations].[低分子量胸腺制剂的辐射防护作用]
Radiats Biol Radioecol. 1994 Jul-Oct;34(4-5):663-70.
10
[Use of T-activin and thymalin in the treatment of ophthalmic herpes].T-激活素和胸腺素在眼科疱疹治疗中的应用
Vestn Oftalmol. 1991 Sep-Oct;107(5):51-4.

引用本文的文献

1
Inhaled drug delivery for tuberculosis therapy.吸入式药物传递系统治疗结核病。
Pharm Res. 2009 Nov;26(11):2401-16. doi: 10.1007/s11095-009-9957-4.
2
Dry powder PA-824 aerosols for treatment of tuberculosis in guinea pigs.干粉 PA-824 气溶胶治疗豚鼠结核病。
Antimicrob Agents Chemother. 2010 Apr;54(4):1436-42. doi: 10.1128/AAC.01471-09. Epub 2010 Jan 19.
3
Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model.用于豚鼠模型中治疗结核病的吸入型大孔卷曲霉素颗粒
Antimicrob Agents Chemother. 2007 Aug;51(8):2830-6. doi: 10.1128/AAC.01164-06. Epub 2007 May 21.